These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions. Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002 [TBL] [Abstract][Full Text] [Related]
4. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation. Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132 [TBL] [Abstract][Full Text] [Related]
5. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor. Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases. Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182 [TBL] [Abstract][Full Text] [Related]
7. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802 [TBL] [Abstract][Full Text] [Related]
8. Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation. Donthamsetti P; Gallo EF; Buck DC; Stahl EL; Zhu Y; Lane JR; Bohn LM; Neve KA; Kellendonk C; Javitch JA Mol Psychiatry; 2020 Sep; 25(9):2086-2100. PubMed ID: 30120413 [TBL] [Abstract][Full Text] [Related]
9. Multiple signaling routes involved in the regulation of adenylyl cyclase and extracellular regulated kinase by dopamine D(2) and D(3) receptors. Jin M; Min C; Zheng M; Cho DI; Cheong SJ; Kurose H; Kim KM Pharmacol Res; 2013 Jan; 67(1):31-41. PubMed ID: 23059541 [TBL] [Abstract][Full Text] [Related]
10. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814 [TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of biased agonism at the dopamine D₂ receptor. Weichert D; Banerjee A; Hiller C; Kling RC; Hübner H; Gmeiner P J Med Chem; 2015 Mar; 58(6):2703-17. PubMed ID: 25734236 [TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor. Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247 [TBL] [Abstract][Full Text] [Related]
14. Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. Weïwer M; Xu Q; Gale JP; Lewis M; Campbell AJ; Schroeder FA; Van de Bittner GC; Walk M; Amaya A; Su P; D Ordevic L; Sacher JR; Skepner A; Fei D; Dennehy K; Nguyen S; Faloon PW; Perez J; Cottrell JR; Liu F; Palmer M; Pan JQ; Hooker JM; Zhang YL; Scolnick E; Wagner FF; Holson EB ACS Chem Biol; 2018 Apr; 13(4):1038-1047. PubMed ID: 29485852 [TBL] [Abstract][Full Text] [Related]
15. Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice. Park SM; Chen M; Schmerberg CM; Dulman RS; Rodriguiz RM; Caron MG; Jin J; Wetsel WC Neuropsychopharmacology; 2016 Feb; 41(3):704-15. PubMed ID: 26129680 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum. Martínez-Pinilla E; Rodríguez-Pérez AI; Navarro G; Aguinaga D; Moreno E; Lanciego JL; Labandeira-García JL; Franco R Biochem Pharmacol; 2015 Jul; 96(2):131-42. PubMed ID: 25986885 [TBL] [Abstract][Full Text] [Related]
17. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists. Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399 [TBL] [Abstract][Full Text] [Related]